Announcements Trials
Browse Landscape

Status

No longer available 2Approved for marketing 2Available 1

Sponsor Class

OTHER 5

Study Type

Interventional 1261Observational 116Expanded_access 5

Sponsor

Cancer Type

Genitourinary 4Head & Neck 1

Conditions

Prostatic Neoplasms 4Parathyroid Neoplasms 1

Interventions

3-Iodobenzylguanidine 9Amifampridine 6nilotinib 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 5trametinib 4pembrolizumab 4gallium 68 PSMA-11 4fludarabine 4elotuzumab 4dabrafenib 4Nivolumab 4Bortezomib 4Afatinib 4venetoclax 3regorafenib 3midostaurin 3fludarabine phosphate 3TIC10 compound 3Sunitinib 3Prednisone 3Lenalidomide 3Ipilimumab 3Everolimus 3Dexamethasone 3Crizotinib 3Capecitabine 3Axitinib 3Alpelisib 3Abiraterone Acetate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Expanded_access × Magnetic Resonance Spectroscopy × Clear all
NCT07218224 2025-10-20

Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

University of California, San Francisco

Available
Head & Neck

Parathyroid Neoplasms

NCT04809584 2024-12-19

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

Stanford University

Approved for marketing
Genitourinary

Prostatic Neoplasms

NCT05002465 2023-09-11

Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

University of Texas Southwestern Medical Center

No longer available
Genitourinary

Prostatic Neoplasms

NCT03501940 2022-01-21

F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer

Stanford University

No longer available
Genitourinary

Prostatic Neoplasms

NCT04377152 2021-03-01

Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer

University of California, San Francisco

Approved for marketing
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡